Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07212322) titled 'A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases' on Sept. 30.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Condition:
Systemic Lupus Erythematosus
Idiopahic Inflammatory Myopathies
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Sjogren's Syndrome
Antiphospholipid Syndrome
Immune Thrombocytopenia
Systemic Sclerosis
Intervention:
Drug: CD19 UCAR-T cells
Recruitment Status: Not recruiting
Phase: N...